Assertion: antibody | /r/CapableOf | target 4-1bb
Facets:
Source sentences:
text: Safety is also a major concern for agonistic Abs since one antibody, urelumab, targeting 4-1BB has been stopped for clinical trials following the occurrence of two hepatotoxicity-related deaths .